Taken together, these data indicate that both host-derived NE and Aspergillus-derived proteases have the capacity to cleave Dectin-1 and other CLRs in the lungs of patients with CF, potentially inhibiting immune responses to Aspergillus, thereby reducing the ability to clear Aspergillus from the airway. The gene discussed is LARS1; the disease is cystic fibrosis.